Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Deadline: Jul 27, 2021

Grant amount: Up to US $275,000

Fields of work: Mental Health & Psychiatric Diseases

Applicant type: Organizations

Funding uses: Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

The purpose of this funding opportunity announcement (FOA) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders. Applications are sought that will either

  • Develop novel brain stimulation devices or
  • Significantly enhance, by means of hardware/software improvements, the effectiveness of brain stimulation devices that are currently U.S. Food and Drug Administration (FDA)-approved or cleared.

Novel devices should move beyond existing electrical/magnetic stimulation and develop new stimulation techniques capable of increased spatiotemporal precision as well as multi-focal, closed-loop approaches. Applications seeking to develop new capabilities should focus on significant enhancement of the spatial resolution, depth of delivery, and/or precision of the device. Incremental changes to existing devices (e.g., software updates)are not within the scope of this announcement. Applications should be submitted by multi-disciplinary teams with diverse expertise including systems neuroscience, engineering, clinical, and regulatory affairs.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities

This page was last reviewed October 27, 2018 and last updated October 27, 2018